Rankings
▼
Calendar
TGTX Q4 2018 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TGTX
TG Therapeutics, Inc.
$5B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$38,000
-0.2% YoY
Gross Profit
$38,000
100.0% margin
Operating Income
-$54M
-142500.0% margin
Net Income
-$54M
-141736.8% margin
EPS (Diluted)
$-0.66
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$84M
Total Liabilities
$60M
Stockholders' Equity
$24M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$38,000
$38,095
-0.2%
Gross Profit
$38,000
$38,095
-0.2%
Operating Income
-$54M
-$31M
-74.5%
Net Income
-$54M
-$31M
-74.5%
← FY 2018
All Quarters
Q1 2019 →